| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $2.39 | $2.56 | $3.26 | $3.16 | $0.40 | $0.69 | $0.59 | $0.23 |
| EPS (Diluted) | $2.39 | $2.55 | $3.26 | $3.16 | $0.40 | $0.69 | $0.59 | $0.23 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.2B | $5.8B | $5.5B | $5.3B | $4.7B | $3.8B | $3.2B | $2.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.4B | $0.2B | $0.1B | $0.7B | $0.5B | $0.2B | $0.0B | $0.0B |
| Total Liabilities | $5.6B | $5.2B | $4.9B | $4.9B | $4.3B | $3.5B | $3.0B | $2.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.6B | $0.6B | $0.5B | $0.4B | $0.4B | $0.3B | $0.3B | $0.2B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.0B | $0.1B | $0.1B | $0.0B | $0.1B | $0.0B | $0.0B |
| Investing Cash Flow | $-0.2B | $-0.1B | $-0.8B | $-0.4B | $-0.2B | $-0.4B | $-0.5B | $-0.2B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.4B | $0.2B | $0.1B | $0.6B | $0.5B | $0.5B | $0.4B | $0.2B |